Trimarchi Thomas

Insider profile

Performance

Overall performance
0.7

Performance over holding periods
0.7
30 days 90 days 120 days
Average return -4% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Trimarchi Thomas's trades of BridgeBio Pharma Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-05-19 2026-05-18 PlS Planned sale
4,050 -1.3%
143.35
US$974,647
4,050 -1.3% 143.35 US$974,647
2026-05-19 2026-05-18 PlS Planned sale
82,617 +10.4%
173.96
US$3,400,295
82,617 +10.4% 173.96 US$3,400,295
2026-05-18 2026-05-18 PrS Proposed sale
54,784
340.12
US$3,007,301
54,784 340.12 US$3,007,301
2026-02-18 2026-02-17 PlS Planned sale
200 -0.1%
75.38
US$15,076
200 -0.1% 75.38 US$15,076
2026-02-18 2026-02-17 PlS Planned sale
13,400 -3.8%
74.71
US$1,001,071
13,400 -3.8% 74.71 US$1,001,071
2026-02-17 2026-02-17 PrS Proposed sale
13,600
74.72
US$1,016,147
13,600 74.72 US$1,016,147
2025-11-18 2025-11-17 PlS Planned sale
6,956 -1.8%
66.84
US$464,938
6,956 -1.8% 66.84 US$464,938
2025-11-18 2025-11-17 PlS Planned sale
9,978 -2.5%
66.19
US$660,467
9,978 -2.5% 66.19 US$660,467
2025-11-17 2025-11-17 PrS Proposed sale
16,934
66.46
US$1,125,403
16,934 66.46 US$1,125,403
2025-08-22 2025-08-21 S Sale
42,237 -9.1%
49.48
US$2,090,081
42,237 -9.1% 49.48 US$2,090,081
2025-08-21 2025-08-21 PrS Proposed sale
42,237
49.48
US$2,090,077
42,237 49.48 US$2,090,077
2025-08-19 2025-08-18 PlS Planned sale
1,973 -0.4%
50.94
US$100,512
1,973 -0.4% 50.94 US$100,512
2025-08-19 2025-08-18 PlS Planned sale
15,380 -3.2%
50.14
US$771,210
15,380 -3.2% 50.14 US$771,210
2025-08-18 2025-08-18 PrS Proposed sale
17,353
50.23
US$871,723
17,353 50.23 US$871,723